Bi-Flow is first bidirectional femoral arterial cannula validated for 29 days’ use LONDON--(BUSINESS WIRE)-- LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, ...
The current trend of using two cannulas to place most newborns in respiratory failure on life-sustaining extracorporeal membrane oxygenation (ECMO), one in the right internal jugular vein and a second ...
The current trend of using two cannulas to place most newborns in respiratory failure on life-sustaining ECMO, one in the right internal jugular vein and a second in the right common carotid artery, ...
Every day we're hearing about the number of coronavirus cases in Australia, how many people are in hospital, in intensive care units and on ventilators. But there is another technique you may not have ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. U.S. hospitalizations requiring ECMO totaled $908 ...
The ECMO machine acts as an artificial heart and lung for a patient whose own heart or lungs cannot provide enough blood to the body. The pneumonia presented with the novel coronavirus disease 2019 ...
The El Paso Physician is available to stream on pbs.org and the free PBS App, available on iPhone, Apple TV, Android TV, Android smartphones, Amazon Fire TV, Amazon Fire Tablet, Roku, Samsung Smart TV ...
LONDON--(BUSINESS WIRE)--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its Bi-Flow Extracorporeal Membrane Oxygenation (ECMO) cannula earned ...
Bi-Flow is first bidirectional femoral arterial cannula validated for 29 days’ use LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results